BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23291450)

  • 1. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice.
    Koide M; Kobayashi Y; Ninomiya T; Nakamura M; Yasuda H; Arai Y; Okahashi N; Yoshinari N; Takahashi N; Udagawa N
    Endocrinology; 2013 Feb; 154(2):773-82. PubMed ID: 23291450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boric acid inhibits alveolar bone loss in rats by affecting RANKL and osteoprotegerin expression.
    Sağlam M; Hatipoğlu M; Köseoğlu S; Esen HH; Kelebek S
    J Periodontal Res; 2014 Aug; 49(4):472-9. PubMed ID: 24033134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.
    Jin Q; Cirelli JA; Park CH; Sugai JV; Taba M; Kostenuik PJ; Giannobile WV
    J Periodontol; 2007 Jul; 78(7):1300-8. PubMed ID: 17608585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periodontal disease-associated compensatory expression of osteoprotegerin is lost in type 1 diabetes mellitus and correlates with alveolar bone destruction by regulating osteoclastogenesis.
    Silva JA; Lopes Ferrucci D; Peroni LA; de Paula Ishi E; Rossa-Junior C; Carvalho HF; Stach-Machado DR
    Cells Tissues Organs; 2012; 196(2):137-50. PubMed ID: 22301390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.
    Yamamoto Y; Udagawa N; Matsuura S; Nakamichi Y; Horiuchi H; Hosoya A; Nakamura M; Ozawa H; Takaoka K; Penninger JM; Noguchi T; Takahashi N
    Endocrinology; 2006 Jul; 147(7):3366-74. PubMed ID: 16627581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local osteoprotegerin gene transfer to periodontal tissue inhibits lipopolysaccharide-induced alveolar bone resorption.
    Chen R; Kanzaki H; Chiba M; Nishimura M; Kanzaki R; Igarashi K
    J Periodontal Res; 2008 Apr; 43(2):237-45. PubMed ID: 18086145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice.
    Piemontese M; Xiong J; Fujiwara Y; Thostenson JD; O'Brien CA
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E587-93. PubMed ID: 27460899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total oxidant status and bone resorption biomarkers in serum and gingival crevicular fluid of patients with periodontitis.
    Baltacıoğlu E; Kehribar MA; Yuva P; Alver A; Atagün OS; Karabulut E; Akalın FA
    J Periodontol; 2014 Feb; 85(2):317-26. PubMed ID: 23701481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats.
    Sağlam M; Köseoğlu S; Hatipoğlu M; Esen HH; Köksal E
    J Appl Oral Sci; 2015; 23(1):33-41. PubMed ID: 25760266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) in Meckel's cartilage compared with developing endochondral bones in mice.
    Sakakura Y; Tsuruga E; Irie K; Hosokawa Y; Nakamura H; Yajima T
    J Anat; 2005 Oct; 207(4):325-37. PubMed ID: 16191162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of chitosan oligosaccharide on alveolar bone resorption, Th17/Treg balance and OPG/RANKL/RANK pathway in periodontitis rats].
    Zhang L; Liu YS; Wu YF; Fu QY
    Shanghai Kou Qiang Yi Xue; 2021 Jun; 30(3):237-242. PubMed ID: 34476437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17/Treg imbalance.
    Cafferata EA; Castro-Saavedra S; Fuentes-Barros G; Melgar-Rodríguez S; Rivera F; Carvajal P; Hernández M; Cortés BI; Cortez C; Cassels BK; Vernal R
    J Periodontol; 2021 Jan; 92(1):123-136. PubMed ID: 32490537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
    Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and bone loss in periodontal disease.
    Cochran DL
    J Periodontol; 2008 Aug; 79(8 Suppl):1569-76. PubMed ID: 18673012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor activator of NF-κB ligand-osteoprotegerin system in pulpal and periapical disease.
    Belibasakis GN; Rechenberg DK; Zehnder M
    Int Endod J; 2013 Feb; 46(2):99-111. PubMed ID: 22900632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
    Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
    J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.